PRM — Proteome Sciences Cashflow Statement
0.000.00%
Last trade - 00:00
- £9.74m
- £21.19m
- £5.03m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.036 | 0.245 | 0.072 | 1.32 | -2.44 |
Depreciation | |||||
Non-Cash Items | 0.418 | 0.312 | 0.882 | 0.999 | 1.41 |
Other Non-Cash Items | |||||
Changes in Working Capital | -0.451 | 0.861 | -0.374 | -0.29 | 0.429 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 0.02 | 1.58 | 0.793 | 2.14 | -0.481 |
Capital Expenditures | -0.058 | -0.013 | -0.204 | -0.319 | -0.237 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0 | — | — | 0 | -0.187 |
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.058 | -0.013 | -0.204 | -0.319 | -0.424 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -0.058 | -0.146 | -0.4 | -0.209 | -1.06 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.159 | 1.41 | 0.177 | 1.61 | -1.97 |